Molecular Mechanisms and Innovative Therapeutic Approaches in Inflammatory Diseases, Pioneering Precision Medicine Solutions

Dear Colleagues,

Inflammatory diseases, ranging from autoimmune disorders to chronic inflammatory conditions, pose significant challenges to global health. The complexity of inflammation involves intricate molecular pathways, including immune system dysregulation, cytokine signaling, and oxidative stress, which vary among individuals and disease states. Advances in molecular biology and precision medicine are unlocking new insights into these mechanisms, offering the potential for highly targeted and effective therapies. This Special Issue aims to delve into the molecular mechanisms that drive inflammatory diseases, with a focus on identifying novel therapeutic targets and pathways. By exploring innovative therapeutic approaches—such as biologics, small molecules, gene therapies, and personalized treatment regimens—this Special Issue will shed light on the future of inflammation treatment through precision medicine. We invite submissions that provide groundbreaking research, clinical studies, and reviews on molecular drivers of inflammation, disease biomarkers, and personalized therapeutic strategies that hold the potential to transform patient outcomes in inflammatory diseases.

Dr. Hector A. Cabrera-Fuentes
Prof. Dr. Klaus T. Preissner
Prof. Dr. Elisabeth Deindl
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.